ABSTRACT
the transparency, integrity, and reproducibility of our study findings. 
INTRODUCTION METHODS

75
Study Design
76
This study is a pilot multicentre prospective cohort study to primarily assess feasibility of our 77 recruitment, retention and data collection strategies, and to collect preliminary data on 
Sample Size
86
Based on the statistic that 1 in 50 women present to fracture clinics because of an IPV-related 87 injury (PRAISE Investigators, 2013), we aim to recruit 50 women at each of 5 sites (250 total).
88
We determined a priori that the study will be feasible if loss to follow-up is less than 15% and 89 adherence to study windows is 75% or greater. We believe that our loss to follow-up will be 90 about 10%, therefore using the confidence interval approach suggested by Thabane et al. (2010) 91 we require 214 patients to achieve a 5% margin of error (which will generate a confidence 92 interval that excludes 15%). We believe that the adherence to study windows will be over 80%,
93
therefore we require 214 patients to achieve a 6% margin of error (which will generate a 94 confidence interval that excludes 75%). Therefore, 250 participants will be sufficient to assess 95 our feasibility outcomes.
The primary analysis will be descriptive. We will report recruitment, missed visits, out of window 135 visits, participant completion data, and completed form data as counts and percentages with 95% 136 confidence intervals (Tables 1 and 2 ).
138
Based on the primary analyses, we will report whether the feasibility criteria have been met, and 139 recommend modifications to the protocol for any planned definitive studies, if needed.
141
Feasibility Criteria
142
We have set the following criteria for feasibility: We will present the percentage of patients with injury-related complications descriptively (Table   174 3) by group (experienced IPV versus not). We will compare across groups using binary logistic 
179
We will report odds ratios with 95% CIs (Table 4) . Changes in abuse severity and type of abuse 230 We will graphically present the proportion of patients who experienced no abuse, a stable level of 231 abuse, escalating abuse, and de-escalating abuse over 12 months with 95% CI. standard trapezoidal rules (CADTH, 2015) . Utility will be presented as quality adjusted life years 238 (QALYs) for each group, with 95% CI, where 1 represents full health and 0 represents death.
239
The difference between each group will be presented as QALYs lost with 95% CI. (Table 10 ). We will also report the percentage of participants who move forward through the 249 stages of change, move backward, or stay at the same stage at 1-month, 3-months, 6-months, 9-250 months, and 12-months compared to baseline (Table 11 ). 
241
251
Visit
Stayed the same Moved forward Moved backward 1 month* 3 months 6 months 12 months * The 1-month visit is optional for participants whose injury occurred between 4 and 6 weeks 257 before enrollment
